KORU Medical Systems, Inc.
NASDAQ:KRMDMedical - Instruments & Supplies
+$0.06 today
- Market cap
- $149.64M
- Beta
- 0.42
- P/E (TTM)
- -80.2
- EPS (TTM)
- -$0.05
Volume 0.19M
Average 0.13M
KRMD Net Income
Bottom-line profit, the starting point for calculating cash from operations.
KORU Medical Systems, Inc.NASDAQ: KRMD
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income declines year over year
Q1 FY2026 net income of $807.08K (cash outflow) fell 30.8% year over year, ahead of the -57.0% change in trailing-twelve-month net income. Sequentially, it rose 65.8% from the prior quarter. Over 3 fiscal years it compounded at -32.7% a year.
Context
- Net income amounted to 6.4% of revenue in FY2025, down 11.6 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of -$345.67K (-86.9%) for the fiscal year ending Dec 2026, a slowdown from the -56.5% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$807.08K+65.8% QoQ
- Last fiscal yearDec 2025
- -$2.64M-56.5% YoY
- LTMMar 2026
- -$2.28M-57.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -30.8% | +199.6% | +230.4 pp |
| 1 year | -56.5% | -86.9% | -30.4 pp |
| 3-year CAGR | -32.7% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (2.64M) USD
- Year-over-year change
- +56.5%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.64M) | +56.5% |
| FY2024 | 2024-12-31 | (6.07M) | +55.9% |
| FY2023 | 2023-12-31 | (13.74M) | -58.7% |
| FY2022 | 2022-12-31 | (8.66M) | -89.8% |
| FY2021 | 2021-12-31 | (4.56M) | — |
Net Income vs competitors
How KRMD compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -57.0% is the lowest of 10, against a peer median of +21.2%.
- Net income amounts to 5.3% of revenue for KRMD, versus a peer median of 60.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | €83.7M EUR | +24.9% | +44.2% | 512.9% | |
| LTM Mar 2026 | $71.83M USD | +124.8% | -84.4% | 63.6% | |
| LTM Mar 2026 | $65.41M USD | +35.9% | -34.8% | 57.5% | |
| LTM Mar 2026 | $39.2M USD | +21.2% | +14.1% | 207.7% | |
| LTM Mar 2026 | $39.12M USD | -6.4% | +23.7% | 121.2% | |
| LTM Mar 2026 | $37.52M USD | -22.7% | +1.7% | 24.7% | |
| LTM Mar 2026 | $27.31M USD | +0.4% | -6.0% | 60.9% | |
| LTM Mar 2026 | $10.85M USD | -16.3% | -11.8% | 28.9% | |
| LTM Mar 2026 | $7.91M USD | +148.0% | +616.7% | 5.6% | |
| LTM Mar 2026 | $2.28M USD | -57.0% | -32.7% | 5.3% | |
| Peer median (excluding KRMD) | — | +21.2% | +1.7% | 60.9% | |
Competitors are the stored peer set for KRMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (4.56M) | (8.66M) | (13.74M) | (6.07M) | (2.64M) |
| Depreciation & Amortization | 463.13K | 587.14K | 870.39K | 888.47K | 810.5K |
| Deferred Income Tax | (1.82M) | (2.03M) | 3.97M | 0 | 0 |
| Stock-Based Compensation | 2.71M | 3.08M | 2.77M | 2.62M | 2.71M |
| Change in Working Capital | (1.11M) | 1.4M | 1.2M | 1.97M | (319.17K) |
| Accounts Receivables | (1.74M) | (220.17K) | 457.18K | (1.68M) | (489.2K) |
| Inventory | 723.43K | (298.53K) | 2.92M | 677.63K | (874.46K) |
| Accounts Payables | 602.61K | 1.16M | (1.42M) | 674.78K | 617.5K |
| Other Working Capital | (698.28K) | 758.15K | (760.19K) | 2.3M | 426.99K |
| Other Non-Cash Items | (1.01K) | 212.55K | 37.82K | 259.55K | (104.54K) |
| Operating Cash Flow | (4.32M) | (5.4M) | (4.89M) | (319.72K) | 462.41K |
| Capital Expenditures | (375.23K) | (2.8M) | (814.6K) | (1.3M) | (932.52K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (19.99K) | (40.51K) | (31.65K) | (35.62K) | (17.27K) |
| Investing Cash Flow | (366.17K) | (2.8M) | (814.6K) | (1.33M) | (949.79K) |
| Debt Repayment | 505.94K | (127.14K) | (218.87K) | (107.96K) | (379.98K) |
| Common Stock Issued | 2.2M | 406.62K | 0 | 0 | 186.17K |
| Common Stock Repurchased | 0 | 0 | 0 | (97.38K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | (43.19K) | (27.54K) |
| Financing Cash Flow | 2.71M | 279.49K | (218.87K) | (248.53K) | (221.35K) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.98M) | (7.93M) | (5.93M) | (1.9M) | (708.74K) |
| Free Cash Flow | (4.69M) | (8.21M) | (5.71M) | (1.62M) | (470.11K) |
KORU Medical Systems, Inc.
NASDAQ:KRMD
Intrinsic Alpha fair value
Locked
Current Price
$3.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.